Case of a severe vulgaris and foliaceus pemphigus in a young patient treated with rituximab, with subsequent development of chronic urticaria
- 4 June 2020
- journal article
- letter
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 33 (4)
- https://doi.org/10.1111/dth.13665
Abstract
Click on the article title to read more.Keywords
This publication has 10 references indexed in Scilit:
- Associations of pemphigus or pemphigoid with autoimmune disorders in US adult inpatientsJournal of the American Academy of Dermatology, 2020
- Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamineItalian Journal of Dermatology and Venereology, 2019
- Pemphigus subtype: a confounder in determining the association of oral involvement with post‐rituximab relapsesDermatologic Therapy, 2019
- Rituximab therapy in pemphigus: A long-term follow-upDermatologic Therapy, 2018
- Rituximab and low dose oral immune modulating treatment to maintain a sustained response in severe pemphigus patientsJournal of Dermatological Treatment, 2018
- Diagnosis and management of pemphigus: Recommendations of an international panel of expertsJournal of the American Academy of Dermatology, 2018
- A Case of Concomitant Pemphigus Foliaceus and Oral Pemphigus VulgarisHead and Neck Pathology, 2018
- Cutaneous type pemphigus vulgaris: A rare clinical phenotype of pemphigusJournal of the American Academy of Dermatology, 2005
- Common Human Leukocyte Antigen Alleles in Pemphigus Vulgaris and Pemphigus Foliaceus Italian PatientsJournal of Investigative Dermatology, 1999
- Pemphigus with features of both vulgaris and foliaceus variants, associated with antibodies to 160 and 130 kDa antigensBritish Journal of Dermatology, 1998